Advancing Personalized Cancer Care
New AI Predicts Cancer Spread with 80% Accuracy
University of Geneva researchers develop MangroveGS to identify risks of metastasis and recurrence.

A scientist reviews genetic data on a digital display using AI to predict cancer metastasis risks.
Photo: Avantgarde News
Researchers at the University of Geneva have developed MangroveGS, a new artificial intelligence tool designed to predict cancer spread [1]. The system analyzes gene expression patterns to assess the likelihood of metastasis and recurrence [1]. Results show the tool achieves nearly 80% accuracy across multiple cancer types [1]. MangroveGS identifies specific biological signatures that signal whether a tumor will return or migrate [1]. This innovation aims to help doctors tailor individual treatment plans more effectively [1]. The study highlights the tool's consistent performance across various diverse patient profiles [1].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The risk level is set to high because the provided source list contains only one domain, which fails the requirement for at least three independent domains to verify scientific claims.
Sources
Related stories
View allTopics
About the author
Avantgarde News Desk covers advancing personalized cancer care and editorial analysis for Avantgarde News.


